» Articles » PMID: 33129968

Potential Metabolic and Inflammatory Pathways Between COVID-19 and New-onset Diabetes

Overview
Journal Diabetes Metab
Specialty Endocrinology
Date 2020 Nov 1
PMID 33129968
Citations 58
Authors
Affiliations
Soon will be listed here.
Citing Articles

The Influence of COVID-19 in Glycemic Control: Predictive Value of Inflammation and Metabolic Parameters.

Andor M, Man D, Nistor D, Buda V, Dragan S Biomedicines. 2024; 12(11).

PMID: 39595206 PMC: 11592279. DOI: 10.3390/biomedicines12112642.


Prevalence and short-term clinical impacts of new-onset diabetes mellitus among patients with COVID-19 in jazan region, Saudi Arabia.

Mohamed A, Darraj M, Yassin A, Somaili M, Sayed A, Oraibi O BMC Endocr Disord. 2024; 24(1):197.

PMID: 39304825 PMC: 11414278. DOI: 10.1186/s12902-024-01724-z.


Association of COVID-19 infection and the risk of new incident diabetes: a systematic review and meta-analysis.

Zhou J, Wang Y, Xu R Front Endocrinol (Lausanne). 2024; 15:1429848.

PMID: 39253580 PMC: 11381376. DOI: 10.3389/fendo.2024.1429848.


The Relationship Between COVID-19 and the Development of Diabetic Ketoacidosis and New-Onset Type 1 Diabetes Mellitus.

Kellogg C, Haenel 4th L Cureus. 2024; 16(5):e60711.

PMID: 38903308 PMC: 11186703. DOI: 10.7759/cureus.60711.


The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus.

Debuysschere C, Nekoua M, Alidjinou E, Hober D Nat Rev Endocrinol. 2024; 20(10):588-599.

PMID: 38890459 DOI: 10.1038/s41574-024-01004-9.